That bottle of ibuprofen in your medicine cabinet sits at the center of one of fitness culture's loudest arguments. Roughly nine out of ten recreational exercisers reach for it. One camp says it's killing your gains. The other says it's harmless. But when two research teams actually measured what NSAIDs do to muscle growth, they found something neither camp expected: the answer depends entirely on who's taking it.
In a controlled trial, young adults who had never trained regularly took ibuprofen at the maximum over-the-counter dose or low-dose aspirin while following the same training program for eight weeks.
By the end, the ibuprofen group's muscles had grown about half as much. The gap was large and clear — confirmed by MRI, consistent across two different training methods, and verified as real growth rather than fluid retention.
But here's what makes it genuinely unsettling.
The ibuprofen group's workouts looked completely normal. Same effort. Same training performance. Same near-perfect compliance. Not a single metric during their sessions suggested anything was wrong.
The only difference showed up in the results months later — and only because researchers were measuring. If you were living this, you'd have no idea. Your workouts would feel the same. Your soreness would be managed. The cost comes without a signal.
The result nobody saw coming
If this were the whole story, the answer would be simple: daily ibuprofen hurts gains, avoid it. But a 2025 study in experienced lifters with years of training tested a different NSAID — diclofenac — against a true placebo, and found something nobody expected.
Their muscles grew more than twice as much as the placebo group.
Same drug class. Opposite direction.
The most likely explanation is that new muscle needs its inflammatory response to grow. Suppress that response and you suppress the growth signal. Muscle that's been training for years may carry more background inflammation than it needs. In that context, mild suppression might actually clear the way rather than block it.
But the two studies also used different drugs. Ibuprofen blocks inflammation broadly. Diclofenac targets it more narrowly. Whether the reversal comes from who was tested, which drug was used, or both can't be pulled apart from just two studies.
The universal answer — "NSAIDs kill gains" — is at best half the story.
The dose nobody mentions
Here's the part that changes the equation for most people reading this.
The study that found halved muscle growth gave participants three 400-milligram tablets of ibuprofen every single day for 56 consecutive days. That's the maximum over-the-counter dose, taken without a break — roughly 67,200 milligrams total.
One tablet after a particularly brutal leg day is a fundamentally different exposure. The paper itself points to earlier research suggesting that taking NSAIDs only on training days at lower doses doesn't measurably hurt muscle growth. That reference hasn't been checked in our evidence base. But the gap between the study protocol and how most people actually use ibuprofen is huge.
The finding that drives the headlines is about a daily routine, not an occasional decision.
Two studies, four answers
The evidence sorts into four distinct situations, and they don't all point the same direction.
If you're in your first couple years of serious lifting, the research points to keeping daily NSAIDs away from your training blocks. The cost is real, the effect is large, and you won't feel it happening. That's roughly the difference between seeing changes after two months versus four months for the same result.
If you've been training consistently for years, the picture is genuinely unclear. A single small study suggests NSAIDs might actually work in your favor — but it used a different drug, tested 17 people, and hasn't been replicated.
If you're over 40 and managing chronic pain, no study in our evidence base tested adults between 40 and 60. Daily NSAID use at that age carries heart, stomach, and tendon risks that exist no matter what the muscle research says. That's a conversation with your doctor, not a decision from a website.
And if you only take ibuprofen occasionally, the research that found the halving tested something you almost certainly don't do.
What we don't know yet
Two studies. Forty-eight total participants. That's the entire evidence base for this question — and both are small.
The demographic most likely to take NSAIDs daily — adults between 40 and 60 — falls in a complete evidence gap. No dose threshold has been mapped. Whether ibuprofen and diclofenac produce genuinely opposite effects, or whether the reversal is driven entirely by who was being tested, remains an open question.
And there's one more connection worth knowing. Cold water immersion — the post-workout ice bath — targets the same pathways that NSAIDs block. If you're using both after training, you may be hitting the same growth signal twice.
That evidence comes from a much larger body of research with a clearer direction. It connects directly to the invisible cost described here.
Think about your medicine cabinet. That bottle of Advil sitting next to your toothbrush might be quietly taxing your training results without giving you a single signal that anything is wrong. Your workouts would feel identical. Your effort would be the same. Your soreness would be managed. But your muscles would be adapting at roughly half the rate.
That's the finding for daily use at the full over-the-counter dose — the kind of routine someone falls into when their knees ache every morning or their back flares after every deadlift session. One tablet after a brutal leg day is a different universe from three tablets every day for two months. The study that found the halving tested a protocol that almost nobody actually follows.